Tianshi Wang
Tianshi Wang is the of counsel of Global Law Office and specialized in investment funds, PE/VC, M&A, insurance, and life sciences and healthcare. Tianshi Wang specializes in investment funds and PE/VC and has advised on many private fund managers in completing private fund manager registration major changes as well as fund filings, and advised on fund structure design, drafting and negotiation of fund documents, fundraising, fund exit and other fund-related issues, serving clients such as Lilly Asia Ventures, China Life Capital, ICBC, Manulife, International, Dajia Insurance, etc. Tianshi Wang has also advised on many PE/VC and M&A projects for domestic and international companies, such as representing China Life to invest in COFCO, representing Centrium Capital in investing in Meican and Newtech Textile, and representing Lilly Asia Ventures in investing in TargetingOne, etc. · Global Law Office
About
Of Counsel at Global Law Office specialising in investment funds, PE/VC, M&A, insurance, and life sciences & healthcare. Advises private fund managers on registration changes and filings, fund structure design, fund documentation, fundraising and exits, and has acted for clients including Lilly Asia Ventures, China Life Capital, ICBC, Manulife and Dajia Insurance; has also advised on PE/VC and M&A transactions such as China Life’s investment in COFCO, Centrium Capital’s investments in Meican and Newtech Textile, and Lilly Asia Ventures’ investment in TargetingOne.
Practice areas
Office
Expertise
Education
- Beijing Foreign Studies University, LL.M. (2014–2017)
- Washington University in St. Louis, LL.M. (2015–2016)